Furthermore, we introduce a recently appreciated role for the angiotensin converting enzyme-2 (ACE2)/Ang (1–7)/MasR axis of renin angiotensin system (RAS) in stroke, and its therapeutic potential in stroke therapy. This evidence concerns the gene MAS1L and stroke disorder.